» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics(PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

CORESTEM INC

WVB Number : KOR000041929 Country : Republic of Korea
SIC categorization : BIOLOGICAL PDS,EX DIAGNSTICS (2836) ISIN : KR7166480004
FT categorization : DRUGS (433)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Company is a Korea-based bio pharmaceutical company engaged in researching, developing and manufacturing stem cell medicines.
Phone : 82 02 497 3711 Fax : 02 6349 8666
Chairman: : GIL AHN YANG Auditor : DASAN ACCOUNTING CORPORATION
CEO/Managing Director : KWANG SOON KWON

» Company Facts

Net Profit Margin (%) -87.97  
Operating Margin (%) -59.63  
Return on Assets (%) -20.29  
Return on Equity (%) -32.63  
Employees 59  

» Company Financials

  Annual (2020)
Income Statement
('000 KRW )
Sales/Total Revenue 26,357,703  
EBITDA -3,345,594  
EBIT -6,904,964  
Net Income -23,186,579  
Balance Sheet
( '000 KRW)
Total Current Assets 101,760,302  
Total Assets 142,871,320  
Current Liabilities 68,691,044  
Total Liabilities & Debt 75,314,118  
Total Equity 67,557,202  
Cash & Flow
( '000 KRW)
Net Income/Staring Line -22,384,006  
Cash from Operating 4,466,418  
Cash from Investing -34,778,031  
Cash from Financing 61,156,708  
Cash & Equivalent Yr End 33,868,768